The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

Authors

  • Thomas D. Boyer,

    Corresponding author
    1. Liver Research Institute, University of Arizona School of Medicine, Tucson, AZ
    • University of Arizona, Liver Research Institute, AHSC 245136, 1501 N. Campbell Ave., Tucson, AZ 85750
    Search for more papers by this author
    • Conflict of interest: Drs. Boyer and Haskal are paid consultants for W. L. Gore and Associates, Inc., the manufacturer of a polytetrafluoroethylene-covered stent used for TIPS.

  • Ziv J. Haskal

    1. Department of Radiology, Columbia University College of Physicians and Surgeons, New York, NY
    Search for more papers by this author
    • Conflict of interest: Drs. Boyer and Haskal are paid consultants for W. L. Gore and Associates, Inc., the manufacturer of a polytetrafluoroethylene-covered stent used for TIPS.


  • All AASLD Practice Guidelines are updated annually. If you are viewing a Practice Guideline that is more than 12 months old, please visit www.aasld.org for an update in the material.

Ancillary